Company: LDDD
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001213900-25-042963
Chunk: 234

Company: Longduoduo Co Ltd
Filing Date: 2025-05-14
Form: 10-Q
Item: Part II, Item 8
Chunk 234
---
 and
the Company’s effective tax rate was as follows:

    For the Nine Months Ended March 31, 

    2025  
    2024 
  
    Income tax (benefit) at USA statutory rate 
     (21)% 
     (21)%
  
    U.S. valuation allowance 
     21% 
     21%
  
    Income tax (benefit) at USA effective rate 
     (0)% 
     (0)%

The difference between the PRC statutory income tax rate and the PRC
effective tax rate was as follows:

    For the Nine Months Ended March 31, 

    2025  
    2024 
  
    Income tax (benefit) at PRC statutory rate 
     25% 
     25%
  
    Utilization of net operating loss carry forward 
     -% 
     (1)%
  
    PRC valuation allowance 
     (8)% 
     2%
  
    Income tax (benefit) at PRC effective rate 
     17% 
     26%

The Company did not recognize deferred tax assets
since it is not more likely than not that it will realize such deferred taxes. The deferred tax would apply to Longduoduo in the U.S.
and Longduoduo Health Technology and subsidiaries in China.

As of March
31, 2025, Longduoduo Health Technology and its subsidiaries have total net operating loss carry forwards of approximately $395,203 in
the PRC that expire through 2030. Due to the uncertainty of utilizing these carry forwards, the Company provided a 100% allowance
on all deferred tax assets of approximately $11,856 and $9,696 related to its operations in the PRC as of March
31, 2025 and June 30, 2024, respectively. The PRC valuation allowance has increased by $0 and decreased by $38,681 for
the nine months ended March 31, 2025 and 2024,
respectively.

The Company incurred losses from its United States
operations during the nine months ended March 31, 2025 of approximately $193,408. The Company’s
United States operations consist solely of ownership of its foreign subsidiaries, and the losses arise from administration expenses. Accordingly,
management provided a 100% valuation allowance of approximately $254,051 and $213,436 against the deferred tax